Literature DB >> 20863730

3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds.

Julio Caballero1.   

Abstract

Inhibitory activities of flavonoid derivatives against aldose reductase (AR) enzyme were modelled by using CoMFA, CoMSIA and GALAHAD methods. CoMFA and CoMSIA methods were used for deriving quantitative structure-activity relationship (QSAR) models. All QSAR models were trained with 55 compounds, after which they were evaluated for predictive ability with additional 14 compounds. The best CoMFA model included both steric and electrostatic fields, meanwhile, the best CoMSIA model included steric, hydrophobic and H-bond acceptor fields. These models had a good predictive quality according to both internal and external validation criteria. On the other hand, GALAHAD was used for deriving a 3D pharmacophore model. Twelve active compounds were used for deriving this model. The obtained model included hydrophobe, hydrogen bond acceptor and hydrogen bond donor features; it was able to identify the active AR inhibitors from the remaining compounds. These in silico tools might be useful in the rational design of new AR inhibitors.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20863730     DOI: 10.1016/j.jmgm.2010.08.005

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  17 in total

1.  A Computational-Based Approach to Identify Estrogen Receptor α/β Heterodimer Selective Ligands.

Authors:  Carlos G Coriano; Fabao Liu; Chelsie K Sievers; Muxuan Liang; Yidan Wang; Yoongho Lim; Menggang Yu; Wei Xu
Journal:  Mol Pharmacol       Date:  2018-01-02       Impact factor: 4.436

2.  Pentachlorophenol molecule design with lower bioconcentration through 3D-QSAR associated with molecule docking.

Authors:  Xiaolei Wang; Zhenhua Chu; Jiawen Yang; Yu Li
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-18       Impact factor: 4.223

3.  Virtual screening to identify Leishmania braziliensis N-myristoyltransferase inhibitors: pharmacophore models, docking, and molecular dynamics.

Authors:  Juliana Cecília de Carvalho Gallo; Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; Isis Bugia Santana; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-08-29       Impact factor: 1.810

4.  Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.

Authors:  Janay Stefany Carneiro Araujo; Bruno Cruz de Souza; David Bacelar Costa Junior; Larissa de Mattos Oliveira; Isis Bugia Santana; Angelo Amâncio Duarte; Pedro Sousa Lacerda; Manoelito Coelho Dos Santos Junior; Franco Henrique Andrade Leite
Journal:  J Mol Model       Date:  2018-07-28       Impact factor: 1.810

5.  Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors.

Authors:  Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; David Bacelar Costa Junior; Isis Bugia Santana; Angelo Amâncio Duarte; Franco Henrique Andrade Leite; Raquel Guimarães Benevides; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-10-16       Impact factor: 1.810

6.  3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.

Authors:  Udit Chaube; Hardik Bhatt
Journal:  Mol Divers       Date:  2017-06-02       Impact factor: 2.943

7.  A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.

Authors:  Huiding Xie; Lijun Chen; Jianqiang Zhang; Xiaoguang Xie; Kaixiong Qiu; Jijun Fu
Journal:  Int J Mol Sci       Date:  2015-05-29       Impact factor: 5.923

8.  Three-dimensional quantitative structure-activity relationships and docking studies of some structurally diverse flavonoids and design of new aldose reductase inhibitors.

Authors:  Utpal Chandra De; Tanusree Debnath; Debanjan Sen; Sudhan Debnath
Journal:  J Adv Pharm Technol Res       Date:  2015 Jan-Mar

9.  3D QSAR studies, pharmacophore modeling and virtual screening on a series of steroidal aromatase inhibitors.

Authors:  Huiding Xie; Kaixiong Qiu; Xiaoguang Xie
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

10.  The discovery of potentially selective human neuronal nitric oxide synthase (nNOS) Inhibitors: a combination of pharmacophore modelling, CoMFA, virtual screening and molecular docking studies.

Authors:  Guanhong Xu; Yue Chen; Kun Shen; Xiuzhen Wang; Fei Li; Yan He
Journal:  Int J Mol Sci       Date:  2014-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.